Parvovirus B19 (Human), IgG/IgM

Alphabetical Test listing

Parvovirus B19 (Human), IgG/IgM-13537

  
Parvovirus B19 (Human), IgG/IgM
  
13537
  
LAB13537
  
PARVOB19AB
  
Human Parvovirus B19, IgG, IgM
  

Differential diagnosis of acute or recent infection from past infection with human parvovirus associated with erythema infectiosum (fifth disease), aplastic crisis, and fetal infection.

  
Serum
  
  
1.0 mL
  
0.5 mL
  

Spin

  

Gold serum separator (SST) tube

  
  

Spin and separate

  
  

Ambient (preferred) - 14 days

Refrigerated - 14 days

Frozen - 14 days

  
  • Hemolysis
  • Lipemia
  • Gross bacterial contamination
  
LabCorp Burlington (163303): R-LC
  
Mo - Fr
  
1 - 3 days
  

Enzyme immunoassay (EIA)

  

Negative:

IgG: < 0.9 index

IgM: < 0.9 index

  

IgM antibodies are detectable two weeks after exposure. IgG antibody production usually occurs 18 to 24 days after exposure. The presence of IgM antibodies to parvovirus B19 provides definite evidence of recent infection.

  
86747 x 2
  
Result 5273-8
  
04/10/2019
  
05/20/2019